Skip to main content
Toggle navigation
Search
Home
Emerging Technologies including GRID, LATTICE, Microbeam, and FLASH Radiotherapies
Emerging Technologies including GRID, LATTICE, Microbeam, and FLASH Radiotherapies
Type here to filter the list
An OAR Trace Method to Enable Highly Conformal FLASH Treatment for Proton Pristine Bragg Peak Delivery Technique
Favorite
Comparative Efficiency of Atlas-Based OAR Contouring versus Manual Contouring: Volume and Dosimetric Impact in Stereotactic Radiotherapy for Multiple Metastases
Favorite
Exploring the Feasibility and Potential of Spatially Fractionated Radiotherapy for Treating Glioblastoma Multiforme (GBM)
Favorite
Feasibility of a Lead GRID Collimator for Electron GRID Therapy
Favorite
Guidelines for Clinical Implementation of LATTICE Radiotherapy for the Treatment of Unresectable Bulky Uterine Cervical Cancer
Favorite
Immune Effects of Spatially Fractionated Radiation Therapy in Triple Negative Breast Cancer
Favorite
Patient-Reported Clinical Outcomes of MLC-Based Spatially Fractionated Radiotherapy Following Offline Adaptive Radiotherapy for Large and Bulky Unresectable Head and Neck Tumors
Favorite
Pencil Beam Scanning Proton LATTICE Radiotherapy: Single-Field versus Multi-Field Optimization
Favorite
Practical Considerations for LATTICE Radiotherapy to Extremely Large Target Volumes
Favorite
Radiobiological Modeling of Indirect Cell-Kill Mechanisms in Spatially Fractionated Radiation Therapy (SFRT) Treatment of Large and Bulky Unresectable Tumors
Favorite
Randomized Trial of Linear Accelerator Generated Mini Beam Radiation Treatment: The Final Report and Future Possibilities
Favorite
Rapid VMAT LATTICE Therapy Planning Using Deep Learning Predicted Synthetic CT from Diagnostic CT Scans
Favorite
Reinterpreting Biological Equivalent Uniform Dose for LATTICE Radiotherapy
Favorite
ShotCaller: An Automated Target Placement Algorithm to Streamline Spatially Fractioned Radiation Therapy Treatment Planning
Favorite
Threshold Dose in Spatially Fractionated Radiation Therapy for Preclinical Triple-Negative Breast Cancer
Favorite
